Travere Therapeutics
Price & Volume
Stats
See moreOpen | $66.78 |
Previous Close | $67.52 |
Day Range | $65.39-$66.97 |
52W Range | $17.27-$67.85 |
Market Cap | $6.3B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $591.3M |
Revenue Growth (YoY) | 48.2% |
Gross Profit (12 Mos) | $350.1M |
Diluted EPS | -$0.73 |
News
See moreYahoo Finance • 22 days ago
This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
Yahoo Finance • 24 days ago
Travere signals potential for more than $3B in peak annual FILSPARI sales as FSGS launch exceeds expectations
Yahoo Finance • last month
This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026
Yahoo Finance • last month
Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm
About
CEO | Dr. Eric M. Dube Ph.D. |
Address | 3611 Valley Centre Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 497 |